Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Brain-derived neurotrophic factor polymorphism Val66Met protects against cancer-related fatigue.

Translational psychiatry - 26 Aug 2020

Feng Li Rebekah, Juneau Paul, Regan Jeniece M, Liwang Josephine, Alshawi Sarah, Wang Angela, Saligan Leorey N

Abstract excerpt

Cancer-related fatigue is an extremely common and debilitating psychiatric symptom that affects up to 80% of cancer patients. Despite its negative impact on the patient's quality of life, there is no well-established biomarker or mechanisms associated with this debilitating condition. The functional brain-derived neurotrophic factor (BDNF) Val66Met single nucleotide polymorphism (SNP) has been associated with a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain-Derived Neurotrophic Factor
Share to Fatigue

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genotype

Share to Neoplasms

Share to Nerve injury and regeneration

Share to Polymorphism, Single Nucleotide

Share to Quality of Life

Source

Open in PubMed Open full text

Identifiers

PMID: 32848137
DOI: 10.1038/s41398-020-00990-4
PMCID: PMC7450091

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Brain-derived neurotrophic factor polymorphism Val66Met protects against cancer-related fatigue.PMID 32848137Read ↗

Brain-Derived Neurotrophic Factor rs6265 polymorphism is associated with severe cancer-related fatigue and neuropathic pain in female cancer survivors.Semantic proximity Read ↗

Brain-derived neurotrophic factor as a biomarker in cancer-related cognitive impairment among adolescent and young adult cancer patients.Semantic proximity Read ↗

The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression.Semantic proximity Read ↗

Genomic Variants Associated With Cancer-Related Fatigue: A Systematic ReviewSemantic proximity Read ↗

Brain-derived neurotrophic factor and mental disorders.Semantic proximity Read ↗

Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer.Semantic proximity Read ↗

Susceptibility and severity of cancer-related fatigue in colorectal cancer patients is associated with SLC6A4 gene single nucleotide polymorphism rs25531 A>G genotype.Semantic proximity Read ↗

Brain-derived neurotrophic factor Val66Met polymorphism and alcohol-related phenotypes.Semantic proximity Read ↗

Associations of brain-derived neurotrophic factor rs6265 polymorphism and cognitive function in breast cancer survivors from a cross-sectional study.Semantic proximity Read ↗

Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.Semantic proximity Read ↗

Perspectives on miRNAs directly targeting BDNF for cancer diagnosis and treatment (Review)Semantic proximity Read ↗

BDNF gene: functional Val66Met polymorphism in mood disorders and schizophrenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.